Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Clin Cancer Res. 2010 May 26;16(15):3875–3886. doi: 10.1158/1078-0432.CCR-10-0483

Fig. 2.

Fig. 2

CXCR2 controls ovarian tumor growth. When in vitro tumorigenicity was tested by soft agar, the number of colonies was decreased in the presence of CXCR2 shRNA (CXCR2i; A). Silencing of CXCR2 inhibited in vivo tumor formation by more than 90% in nude mice injected with T29Gro-1, T29H, or SKOV3 cells (B–D). Error bars, 95% confidence intervals.